BAUG Performance — Innovator U.S. Equity Buffer ETF - August
Data updated: 2026-09-28
BAUG returned +8.33% year to date and +15.04% over one year to Jul 2026. Annualised returns are +16.17% over 3 years and +11.40% over 5 years. Against its US Blend category average the fund came out ahead over three years but behind over one: $100 invested three years ago grew to $157, against $147 for the category, and to $115 over one year, against $120. Volatility over the past three years was 9.17% a year. In the 12 months to Jul 2026 the fund took in a net $4.5M, and assets reached $195.29M.
BAUG Growth of $100
What $100 invested in Innovator U.S. Equity Buffer ETF - August grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Blend category average over the same months.
| Period | BAUG | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $115 | $120 |
| 3 years (Aug 2023 – Jul 2026) | $157 | $147 |
| 5 years (Aug 2021 – Jul 2026) | $172 | $143 |
| Since data start (Feb 2020 – Jul 2026) | $203 | $169 |
BAUG Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +8.33% |
| 1 year | +15.04% |
| 3 years (annualised) | +16.17% |
| 5 years (annualised) | +11.40% |
BAUG Annual Returns
Calendar-year total returns of Innovator U.S. Equity Buffer ETF - August, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +8.33% |
| 2025 | +14.72% |
| 2024 | +21.34% |
| 2023 | +20.05% |
| 2022 | −10.19% |
| 2021 | +12.03% |
| 2020 (Feb–Dec) | +11.57% |
BAUG Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.0% | −0.2% | −3.1% | +6.8% | +2.3% | +0.5% | +1.1% | — | — | — | — | — |
| 2025 | +1.9% | −0.7% | −4.0% | −0.6% | +4.8% | +4.2% | +2.5% | +1.6% | +2.3% | +1.0% | +0.5% | +0.7% |
| 2024 | +1.3% | +4.2% | +2.4% | −3.0% | +4.7% | +2.8% | +2.0% | +1.9% | +1.5% | −0.5% | +3.7% | −1.1% |
| 2023 | +4.6% | −1.8% | +2.5% | +0.9% | +0.1% | +5.2% | +3.1% | −1.1% | −3.6% | −1.4% | +6.8% | +3.6% |
| 2022 | −2.8% | −2.0% | +2.9% | −6.2% | +0.6% | −4.0% | +5.9% | −3.1% | −7.0% | +6.1% | +4.4% | −4.4% |
| 2021 | −1.0% | +1.8% | +2.8% | +1.3% | +0.7% | +0.4% | +0.1% | +1.8% | −3.0% | +4.6% | −0.9% | +3.1% |
| 2020 | — | −5.5% | −9.9% | +9.5% | +4.0% | +0.8% | +4.7% | +4.1% | −2.6% | −0.7% | +6.7% | +1.6% |
BAUG Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 9.17%
- 3-year Sharpe ratio: 1.27 (vs 4.5% risk-free rate)
- Best month: +6.79% (Nov 2023)
- Worst month: −4.03% (Mar 2025)
BAUG Fund Flows
Monthly money in and out of Innovator U.S. Equity Buffer ETF - August, from SEC Form N-PORT.
- 12-month net flow: $4.5M
- 12-month gross sales (incl. reinvestments): $67.9M
- Sales ÷ redemptions: 1.07×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $1.4M | $4.1M | −$2.7M |
| Jun 2026 | $0 | $0 | $0 |
| May 2026 | $0 | $2.6M | −$2.6M |
| Apr 2026 | $1.3M | $2.6M | −$1.3M |
| Mar 2026 | $0 | $2.4M | −$2.4M |
| Feb 2026 | $0 | $0 | $0 |
| Jan 2026 | $1.3M | $31.2M | −$29.9M |
| Dec 2025 | $0 | $0 | $0 |
| Nov 2025 | $0 | $4.9M | −$4.9M |
| Oct 2025 | $0 | $2.5M | −$2.5M |
| Sep 2025 | $3.6M | $13.1M | −$9.5M |
| Aug 2025 | $60.4M | $0 | $60.4M |
BAUG Assets Under Management
Net assets of Innovator U.S. Equity Buffer ETF - August by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $195.29M |
| 2026-04-30 | $192.96M |
| 2026-01-31 | $190.84M |
| 2025-10-31 | $221.41M |
| 2025-07-31 | $162.68M |
| 2025-04-30 | $153.73M |
| 2025-01-31 | $186.74M |
| 2024-10-31 | $180.82M |
| 2024-07-31 | $137.54M |
| 2024-04-30 | $157.44M |
| 2024-01-31 | $241.35M |
| 2023-10-31 | $182.04M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.